BackVistagen Therapeutics Overview
Vistagen Therapeutics Inc.

Vistagen Therapeutics Target Price

Analysts' 12-month price predictions for VTGN.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.58

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-12-17JefferiesAndrew Tsai$0.956.2% upsideOpen
2025-12-17Stifel Nicolaus$173.6% upsideOpen
2025-11-17Stifel NicolausPaul Mattheis$121982.6% upsideOpen
2022-07-22JefferiesAndrew Tsai$6941.3% upsideOpen